Prognose
Vi har ingen analytikerdata for denne virksomhed.
Diskussioner i communityet
Der er endnu ingen diskussion om dette aktiv.
Start diskussionNyheder Til nyhedsfeedet
Glanbia raises 2026 forecast after strong first half
Glanbia reported a strong first half with adjusted earnings per share of €0.8124 (+30% currency-adjusted) and revenue of €2.1bn (+7% currency-adjusted). Group EBITDA rose 14.1% currency-adjusted to €275.4m and the EBITDA margin improved to 13.2%. Drivers were strong demand for protein products, price stability at Optimum Nutrition and cost savings; management raised the full-year guidance for adjusted EPS to currency-adjusted growth of 17–20% and increased the transformation savings target to €70m per year by 2027. » Mere på de.investing.com
Glanbia cuts Tirlán representation and reduces board size
The Tirlán Co-operative Society is reducing its representation on the Glanbia board from two directors to one. John Murphy and Bill Carroll will resign on 4 August 2026; Ger O’Brien will be appointed on 5 August 2026 as a Tirlán‑nominated non‑executive director. After the changes, the board will consist of ten directors (two executive, the chair and seven non‑executive, one of whom is from Tirlán). Glanbia reports no further matters requiring disclosure. » Mere på de.investing.com
Tirlán sells 12 million Glanbia shares for €257.6 million
The Tirlán Co-operative Society has completed the sale of 12,000,000 ordinary shares in Glanbia for a total of around €257.6 million. 9,671,170 shares were sold to institutional investors via an accelerated bookbuild, and 2,328,830 shares were sold off‑market to Glanbia as part of an approved targeted buyback; the price for both transactions was €21.47 per share. After settlement (expected around 16 June 2026) and the cancellation of the shares acquired by the company, Tirlán will remain the largest shareholder with 31,548,762 ordinary shares; the cancellation will reduce issued ordinary shares to an expected 239,613,665 and will use €50 million of the ongoing €100 million buyback program. » Mere på de.investing.com
Glanbia: Tirlán to sell around 5% (approx. 12 million shares), Glanbia to buy up to €50m off-market
The Tirlán Co-operative Society plans to sell about 12 million Glanbia shares (≈5% of capital) via an accelerated placement to institutional investors and an off-market sale to Glanbia of up to €50 million. The off-market purchase will be made under an already approved buyback programme and is conditional on completion of the placement; all shares acquired by Glanbia will be cancelled. The price for the off-market purchase will be based on the bookbuilding price; after completion Glanbia intends to disclose the number and price of the shares acquired. » Mere på de.investing.com
Glanbia launches buyback programme of up to €50 million
Glanbia has launched a share buyback programme of up to €50 million, which starts today and runs until 30 September 2026. Shares acquired will be cancelled to reduce share capital; J&E Davy will execute purchases as principal within set parameters and will make buy decisions independently of the company, including during closed trading periods. The programme is part of an overall €100 million initiative and is being carried out under an existing shareholder authorisation that expires at the end of April 2026 and must be renewed for continuation. » Mere på de.investing.com
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalI 2026 har GLANBIA allerede udloddet 0,45 € i udbytte. Den seneste udlodning fandt sted i oktober.
Virksomhedstal
I det seneste kvartal havde GLANBIA en omsætning på 2,04 mia. € og et nettoresultat på 150,71 mio. €
| (EUR) | juni 2026 | YoY |
|---|---|---|
| Omsætning | 2,04 mia. | - |
| Bruttofortjeneste | 542,97 mio. | - |
| Nettoresultat | 150,71 mio. | - |
| EBITDA | 273,2 mio. | - |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 4,71 mia. € |
Antal aktier | 236,87 mio. |
Højeste/laveste i 52 uger | 25,60 € - 13,30 € |
Udbytteafkast | 2,19 % |
Udbytte TTM | 0,45 € |
Beta | 0,45 |
P/E (PE Ratio) | 21,74 |
PEG (PEG Ratio) | 0,20 |
K/I (PB Ratio) | 2,71 |
P/S (PS Ratio) | 1,24 |
Virksomhedsprofil
Glanbia plc driver virksomhed inden for ernæring over hele verden. Virksomheden fremstiller og sælger sportsernæring og livsstilsernæringsprodukter i forskellige formater, herunder pulvere, spiseklare barer og snacks samt drikkeklare drikkevarer, gennem forskellige kanaler, såsom specialforretninger, online og fitnesscentre, samt dagligvare-, drogeri-, masse- og klubkanalerne. Selskabet er involveret i fremstilling og salg af ost, mejeri- og ikke-mejeribaserede ernærings- og funktionelle ingredienser samt vitamin- og mineralpremixer. Derudover beskæftiger selskabet sig med finansiering, forskning og udvikling, ejendoms- og jordhandel, administration af tilgodehavender, ledelse, udlejning af ejendomme, forretningsservice og vægtkontrolløsninger. Det driver en portefølje af brands, herunder OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass og BODY&FIT. Glanbia plc blev grundlagt i 1964 og har hovedkontor i Kilkenny, Irland.
| Navn | GLANBIA |
| CEO | Hugh McGuire Finance |
| Hjemsted | Kilkenny,
kk Irland |
| Websted | |
| Børsnotering | 04.01.2000 |
| Medarbejdere | 5.800 |
Tickersymboler
| Børs | Symbol |
|---|---|
London Stock Exchange | GLB.L |
Pnk | GLAPF |
Frankfurt | GL9.F |
Düsseldorf | GL9.DU |
London | GLB.L |
München | GL9.MU |